Optimizing cystic fibrosis-related diabetes screening in adults using the oral glucose tolerance test (OGTT): a single center mixed methods study.
Background: Early diabetes detection can enhance metabolic outcomes, reducing future risks and complications. Effective diabetes screening remains crucial in the post cystic fibrosis (CF) modulator therapy era whereby treatment with Elexacaftor/Tezacaftor/Ivacaftor (ETI) will lead to an aging CF pop...
| Publicado en: | JBI Evidence Implementation Vol. 24; no. 2; pp. 388 - 398 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | pictorial research tables/charts Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
Apr2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |